{"id":"https://openalex.org/W2126448684","doi":null,"title":"Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.","display_name":"Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.","publication_year":2002,"publication_date":"2002-08-01","ids":{"openalex":"https://openalex.org/W2126448684","mag":"2126448684","pmid":"https://pubmed.ncbi.nlm.nih.gov/12154028"},"language":"en","primary_location":{"id":"pmid:12154028","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12154028","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Patricia A Burke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia A Burke","raw_affiliation_strings":["University of California at Davis, Sacramento Medical Center, Radiodiagnosis and Therapy/Internal Medicine, Sacramento, California 95816, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California at Davis, Sacramento Medical Center, Radiodiagnosis and Therapy/Internal Medicine, Sacramento, California 95816, USA","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111607459","display_name":"Sally J. DeNardo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sally J DeNardo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000221454","display_name":"Laird A. Miers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laird A Miers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061018141","display_name":"Kathleen R. Lamborn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen R Lamborn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108452375","display_name":"S. Matzku","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Siegfried Matzku","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113460761","display_name":"Gerald L. DeNardo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald L DeNardo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.0962,"has_fulltext":false,"cited_by_count":209,"citation_normalized_percentile":{"value":0.97425137,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"62","issue":"15","first_page":"4263","last_page":"72"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cilengitide","display_name":"cilengitide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/alpha-v-beta3-integrin","display_name":"alpha v beta 3 integrin","score":0.9470000267028809},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.9779999852180481},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8489999771118164},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.628000020980835},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.36500000953674316},{"id":"https://openalex.org/keywords/tumor-microvessel-density","display_name":"tumor microvessel density","score":0.675000011920929},{"id":"https://openalex.org/keywords/mutant-p53","display_name":"mutant p53","score":0.7179999947547913},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9440000057220459},{"id":"https://openalex.org/keywords/yttrium-90","display_name":"yttrium-90","score":0.7020000219345093},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7440000176429749},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.6389999985694885},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.34299999475479126},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.8387173414230347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7160264253616333},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5976229906082153},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5689711570739746},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.504001796245575},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5036744475364685},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.44453534483909607},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.4126323163509369},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3956674337387085},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35213804244995117},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30263057351112366},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27319514751434326},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2218274176120758},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.17955949902534485},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.12479719519615173},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012910","descriptor_name":"Snake Venoms","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D019030","descriptor_name":"Receptors, Vitronectin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12154028","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12154028","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2126448684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12154028","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2149237283","display_name":"Translational Multimodality \" Antibody\" Therapy","funder_award_id":"P01CA047829","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":81,"referenced_works":["https://openalex.org/W134095429","https://openalex.org/W198761891","https://openalex.org/W1483432795","https://openalex.org/W1489329946","https://openalex.org/W1492495888","https://openalex.org/W1504652010","https://openalex.org/W1531891842","https://openalex.org/W1542916548","https://openalex.org/W1554380543","https://openalex.org/W1556933114","https://openalex.org/W1559321175","https://openalex.org/W1571487648","https://openalex.org/W1603973043","https://openalex.org/W1658047882","https://openalex.org/W1817837574","https://openalex.org/W1827838868","https://openalex.org/W1868646770","https://openalex.org/W1882558175","https://openalex.org/W1894658937","https://openalex.org/W1910612303","https://openalex.org/W1911989431","https://openalex.org/W1936464499","https://openalex.org/W1943173994","https://openalex.org/W1963409105","https://openalex.org/W1966405860","https://openalex.org/W1968519314","https://openalex.org/W1970730148","https://openalex.org/W1970959706","https://openalex.org/W1976570855","https://openalex.org/W1978718921","https://openalex.org/W1980083933","https://openalex.org/W1994039691","https://openalex.org/W2001753204","https://openalex.org/W2008181555","https://openalex.org/W2011739810","https://openalex.org/W2013840138","https://openalex.org/W2021070333","https://openalex.org/W2023189156","https://openalex.org/W2029773366","https://openalex.org/W2033440675","https://openalex.org/W2034842897","https://openalex.org/W2037761545","https://openalex.org/W2040283898","https://openalex.org/W2046391716","https://openalex.org/W2048640269","https://openalex.org/W2054109520","https://openalex.org/W2057058036","https://openalex.org/W2057306672","https://openalex.org/W2059637625","https://openalex.org/W2061718399","https://openalex.org/W2065097700","https://openalex.org/W2069937695","https://openalex.org/W2073527693","https://openalex.org/W2074580909","https://openalex.org/W2079323372","https://openalex.org/W2082800425","https://openalex.org/W2094901288","https://openalex.org/W2098486046","https://openalex.org/W2104886736","https://openalex.org/W2105713954","https://openalex.org/W2108922094","https://openalex.org/W2113267611","https://openalex.org/W2118654802","https://openalex.org/W2119423559","https://openalex.org/W2120921677","https://openalex.org/W2126486896","https://openalex.org/W2131460331","https://openalex.org/W2132979902","https://openalex.org/W2138302361","https://openalex.org/W2142482145","https://openalex.org/W2144799663","https://openalex.org/W2146183342","https://openalex.org/W2152713316","https://openalex.org/W2154330641","https://openalex.org/W2163182836","https://openalex.org/W2167151663","https://openalex.org/W2264304853","https://openalex.org/W2415309604","https://openalex.org/W2415388925","https://openalex.org/W2424067069","https://openalex.org/W4322717319"],"related_works":["https://openalex.org/W1489329946","https://openalex.org/W2121567543","https://openalex.org/W2046990123","https://openalex.org/W2127449225","https://openalex.org/W2152460974","https://openalex.org/W1993307735","https://openalex.org/W2024998069","https://openalex.org/W2323732596","https://openalex.org/W1999690473","https://openalex.org/W7095667024"],"abstract_inverted_index":{"Although":[0],"metastatic":[1],"breast":[2,93,105,376],"cancer":[3,94,106,377],"is":[4,383],"responsive":[5],"to":[6,35,55,62,230,334],"radioimmunotherapy":[7],"(RIT),":[8],"a":[9,91],"systemic":[10,85],"targeted":[11],"radiation":[12],"modality,":[13],"complete":[14],"and":[15,50,65,100,139,146,161,168,192,263,286,324,343,354,362],"permanent":[16],"remissions":[17],"are":[18],"not":[19,198,328],"typical":[20],"with":[21,53,204,209,215,241,251,294,308,366,369],"single-modality":[22,367],"treatment.":[23],"Antiangiogenic":[24],"agents,":[25],"which":[26,74],"target":[27],"normal,":[28],"proliferating":[29],"endothelial":[30,287],"cells,":[31],"have":[32],"the":[33,67,76,174,216,358],"potential":[34],"provide":[36],"relatively":[37],"nontoxic":[38],"continuous":[39],"inhibition":[40],"of":[41,88,116,149,170,176,213,269,275,284,360,384],"tumor":[42,95,107,200,285],"growth":[43,49,201],"by":[44],"blocking":[45],"new":[46],"blood":[47,162,341],"vessel":[48],"may":[51],"synergize":[52],"RIT":[54,86,127,142,145,226,236,254,292,299,309,323],"increase":[56,84,246,346],"efficacy.":[57],"This":[58],"study":[59],"was":[60,112,302,327,336],"designed":[61],"determine":[63],"whether,":[64],"how,":[66],"cyclic":[68],"Arg-Gly-Asp":[69],"peptide":[70],"Cilengitide":[71,150,195,210,242,335,353],"(EMD":[72],"121974),":[73],"targets":[75],"alpha(v)beta(3)":[77],"integrin":[78],"receptor":[79],"expressed":[80],"on":[81],"neovasculature,":[82],"could":[83],"efficacy":[87,167,212,268,359],"therapy":[89,361,368],"in":[90,109,244,247,304,320,347,372],"human":[92],"model":[96],"having":[97,387],"mutant":[98],"p53":[99],"expressing":[101],"bcl-2.":[102],"HBT":[103],"3477":[104],"response":[108],"nude":[110],"mice":[111,118,123,220,279,297,326],"compared":[113,203,250,293,307,365],"between":[114],"groups":[115,265],"untreated":[117,205],"(n":[119,124],"=":[120,125,137,154,233,257,272],"24),":[121],"Cilengitide-treated":[122],"18),":[126],"(200-260":[128],"mu":[129,224,238],"Ci":[130,225],"(90)Y-labeled":[131],"1,4,7,10-tetraazacyclododecane-N,N',N\",N\"'-tetraacetic":[132],"acid":[133],"(DOTA)-peptide":[134],"ChL6;":[135],"n":[136,153],"46),":[138],"combined":[140,240],"modality":[141],"(CMRIT)":[143],"using":[144],"six":[147],"doses":[148],"(250":[151],"microg/dose;":[152],"41).":[155],"Tumor":[156],"size,":[157],"survival,":[158],"body":[159],"weight,":[160],"counts":[163],"were":[164,180],"monitored":[165],"for":[166,189,219,253,261],"toxicity":[169,332],"therapy.":[171],"To":[172],"clarify":[173],"mechanism":[175],"synergistic":[177],"effect,":[178],"tumors":[179,276,295,306,310,321],"evaluated":[181],"at":[182,311],"selected":[183],"time":[184],"points":[185],"through":[186],"6":[187,312],"days":[188,290,313],"apoptosis,":[190],"proliferation,":[191],"microvessel":[193],"density.":[194],"alone":[196],"did":[197],"alter":[199],"when":[202],"mice,":[206],"but":[207],"CMRIT":[208,270,278,305,325],"increased":[211,267,282,331,357,363],"treatment,":[214],"cure":[217],"rate":[218],"that":[221],"received":[222],"260":[223],"increasing":[227],"from":[228,277,296,322],"15":[229],"53%":[231],"(P":[232,271],"0.011).":[234],"Lower-dose":[235],"(200":[237],"Ci)":[239],"resulted":[243],"less":[245],"cures":[248],"(36":[249],"25%":[252],"alone;":[255],"P":[256,315],"0.514).":[258],"Combined":[259],"analysis":[260],"high-":[262],"low-dose":[264],"demonstrated":[266],"0.020).":[273],"Analysis":[274],"indicated":[280],"significantly":[281,356],"apoptosis":[283,364],"cells":[288],"5":[289],"after":[291],"given":[298],"alone.":[300],"Proliferation":[301],"decreased":[303],"(ANOVA,":[314],"<":[316],"0.05).":[317],"Microvessel":[318],"density":[319],"different.":[329],"No":[330],"attributable":[333],"observed":[337],"based":[338],"upon":[339],"pooled":[340],"sample":[342],"no":[344],"statistical":[345],"mortality.":[348],"In":[349],"conclusion,":[350],"CMRIT,":[351],"combining":[352],"RIT,":[355],"either":[370],"agent,":[371],"an":[373],"aggressive,":[374],"well-studied":[375],"model.":[378],"The":[379],"enhanced":[380],"therapeutic":[381],"synergy":[382],"particular":[385],"note,":[386],"been":[388],"achieved":[389],"without":[390],"additional":[391],"toxicity.":[392]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}